158 related articles for article (PubMed ID: 8959518)
21. Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healing.
Forné M; Viver JM; Esteve M; Fernández-Bañares F; Lite J; Espinós JC; Quintana S; Salas A; Garau J
Am J Gastroenterol; 1998 Jan; 93(1):35-8. PubMed ID: 9448170
[TBL] [Abstract][Full Text] [Related]
22. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Fischbach LA; Bravo LE; Zarama GR; Bravo JC; Ojha RP; Priest EL; Collazos T; Casabon AL; Guerrero LZ; Singh KP; Correa P
Helicobacter; 2009 Apr; 14(2):100-8. PubMed ID: 19298337
[TBL] [Abstract][Full Text] [Related]
23. [Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule].
Martín Mir ML; Val J; Fuentes J; García S; Yus C; Simón MA; Gomollón F
Gastroenterol Hepatol; 1998 Nov; 21(9):432-6. PubMed ID: 9882932
[TBL] [Abstract][Full Text] [Related]
24. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
[TBL] [Abstract][Full Text] [Related]
25. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
[TBL] [Abstract][Full Text] [Related]
26. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol.
Ushiama H; Echizen H; Nachi S; Ohnishi A
Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002
[TBL] [Abstract][Full Text] [Related]
27. Low eradication rates of Helicobacter pylori with omeprazole plus amoxycillin combination in a Turkish population.
Simsek H; Kadayifci A; Tatar G
Am J Gastroenterol; 1996 May; 91(5):1062. PubMed ID: 8633565
[No Abstract] [Full Text] [Related]
28. Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Slomiany BL; Piotrowski J; Majka J; Slomiany A
Scand J Gastroenterol Suppl; 1995; 210():82-4. PubMed ID: 8578215
[TBL] [Abstract][Full Text] [Related]
29. In vitro antagonism of rabeprazole and metronidazole upon clinical isolates of Helicobacter pylori.
Soto A; García A; González CL
Chemotherapy; 2009; 55(5):308-11. PubMed ID: 19556788
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of clarithromycin against intracellular Helicobacter pylori.
Piccolomini R; Di Bonaventura G; Picciani C; Laterza F; Vecchiet J; Neri M
Antimicrob Agents Chemother; 2001 May; 45(5):1568-71. PubMed ID: 11302831
[TBL] [Abstract][Full Text] [Related]
31. Acid inhibition and amoxicillin activity against Helicobacter pylori.
Savarino V; Sandro Mela G; Zentilin P; Vigneri S; Celle G
Am J Gastroenterol; 1993 Nov; 88(11):1975-6. PubMed ID: 8237959
[No Abstract] [Full Text] [Related]
32. In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates of Helicobacter pylori.
Alarcón T; Domingo D; Sánchez I; Díaz de Rojas F; López-Brea M
Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):937-40. PubMed ID: 9031877
[TBL] [Abstract][Full Text] [Related]
33. Crude ethanolic extracts of Garcinia kola seeds Heckel (Guttiferae) prolong the lag phase of Helicobacter pylori: inhibitory and bactericidal potential.
Njume C; Afolayan AJ; Clarke AM; Ndip RN
J Med Food; 2011; 14(7-8):822-7. PubMed ID: 21476930
[TBL] [Abstract][Full Text] [Related]
34. Amoxicillin resistance with beta-lactamase production in Helicobacter pylori.
Tseng YS; Wu DC; Chang CY; Kuo CH; Yang YC; Jan CM; Su YC; Kuo FC; Chang LL
Eur J Clin Invest; 2009 Sep; 39(9):807-12. PubMed ID: 19614952
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
Piotrowski J; Murty VL; Slomiany A; Slomiany BL
Biochem Mol Biol Int; 1995 Mar; 35(3):467-72. PubMed ID: 7773183
[TBL] [Abstract][Full Text] [Related]
36. Stable amoxicillin resistance in Helicobacter pylori.
Dore MP; Kwon DH; Sepulveda AR; Graham DY; Realdi G
Helicobacter; 2001 Mar; 6(1):79. PubMed ID: 11328370
[No Abstract] [Full Text] [Related]
37. In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.
Kanamaru T; Nakano Y; Toyoda Y; Miyagawa KI; Tada M; Kaisho T; Nakao M
Antimicrob Agents Chemother; 2001 Sep; 45(9):2455-9. PubMed ID: 11502514
[TBL] [Abstract][Full Text] [Related]
38. Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.
Matsumoto S; Washizuka Y; Matsumoto Y; Tawara S; Ikeda F; Yokota Y; Karita M
Antimicrob Agents Chemother; 1997 Dec; 41(12):2602-5. PubMed ID: 9420026
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
[TBL] [Abstract][Full Text] [Related]
40. Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
Nakase K; Nakanishi-Yamasaki M; Harada K; Koizumi J; Yamada T; Ikoshi H; Nakaminami H; Noguchi N
J Infect Chemother; 2021 Jul; 27(7):957-961. PubMed ID: 33602640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
